BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu H, Wang M, Dai B, Zhang Y, Yang Y, Li Q, Duan M, Zhang X, Wang X, Li A, Zhang L. Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics. Drug Deliv 2017;24:1216-29. [PMID: 28845698 DOI: 10.1080/10717544.2017.1367976] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Ci T, Zhang W, Qiao Y, Li H, Zang J, Li H, Feng N, Gu Z. Delivery strategies in treatments of leukemia. Chem Soc Rev 2022. [PMID: 35188506 DOI: 10.1039/d1cs00755f] [Reference Citation Analysis]
2 Zhang L, Wang M, Zhu Z, Chen S, Wu H, Yang Y, Che F, Li Q, Li H. A GD2-aptamer-mediated, self-assembling nanomedicine for targeted multiple treatments in neuroblastoma theranostics. Mol Ther Nucleic Acids 2021;26:732-48. [PMID: 34703655 DOI: 10.1016/j.omtn.2021.08.021] [Reference Citation Analysis]
3 Küçükdiler AHE, Yavaşoğlu İ, Selim C, Mutlu CA, Karakuş A, Koyuncu MB, Bilgir O, Ayyıldız O, Tiftik EN, Bolaman AZ. Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey. Leuk Res Rep 2021;16:100280. [PMID: 34849337 DOI: 10.1016/j.lrr.2021.100280] [Reference Citation Analysis]
4 Wu H, Zhang L, Zhu Z, Ding C, Chen S, Liu R, Fan H, Chen Y, Li H. Novel CD123 polyaptamer hydrogel edited by Cas9/sgRNA for AML-targeted therapy. Drug Deliv 2021;28:1166-78. [PMID: 34121564 DOI: 10.1080/10717544.2021.1934191] [Reference Citation Analysis]
5 Nur Y, Gaffar S, Hartati YW, Subroto T. Applications of electrochemical biosensor of aptamers-based (APTASENSOR) for the detection of leukemia biomarker. Sensing and Bio-Sensing Research 2021;32:100416. [DOI: 10.1016/j.sbsr.2021.100416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Zhang L, Wang M, Zhu Z, Ding C, Chen S, Wu H, Yang Y, Che F, Li Q, Li H. A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy. Int J Nanomedicine 2021;16:3217-40. [PMID: 34007175 DOI: 10.2147/IJN.S302450] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhao J, Wang M, Yang Y, Wang G, Che F, Li Q, Zhang L. CD123 thioaptamer protects against sepsis via the blockade between IL-3/CD123 in a cecal ligation and puncture rat model. Nucleosides Nucleotides Nucleic Acids 2021;40:16-31. [PMID: 32985358 DOI: 10.1080/15257770.2020.1815770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Giudice V, Mensitieri F, Izzo V, Filippelli A, Selleri C. Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases. Int J Mol Sci 2020;21:E3252. [PMID: 32375354 DOI: 10.3390/ijms21093252] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
9 Singh A, Myklebust NN, Furevik SMV, Haugse R, Herfindal L. Immunoliposomes in Acute Myeloid Leukaemia Therapy: An Overview of Possible Targets and Obstacles. Curr Med Chem 2019;26:5278-92. [PMID: 31099318 DOI: 10.2174/0929867326666190517114450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Tan Y, Li Y, Tang F. Nucleic Acid Aptamer: A Novel Potential Diagnostic and Therapeutic Tool for Leukemia. Onco Targets Ther 2019;12:10597-613. [PMID: 31824168 DOI: 10.2147/OTT.S223946] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang M, Wu H, Li Q, Yang Y, Che F, Wang G, Zhang L. Novel Aptamer-Functionalized Nanoparticles Enhances Bone Defect Repair By Improving Stem Cell Recruitment. Int J Nanomedicine 2019;14:8707-24. [PMID: 31806966 DOI: 10.2147/IJN.S223164] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
12 Jahanban-Esfahlan A, Seidi K, Jaymand M, Schmidt TL, Majdi H, Javaheri T, Jahanban-Esfahlan R, Zare P. Dynamic DNA nanostructures in biomedicine: Beauty, utility and limits. J Control Release 2019;315:166-85. [PMID: 31669209 DOI: 10.1016/j.jconrel.2019.10.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Reda A, Hosseiny S, El-Sherbiny IM. Next-generation nanotheranostics targeting cancer stem cells. Nanomedicine (Lond) 2019;14:2487-514. [PMID: 31490100 DOI: 10.2217/nnm-2018-0443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
14 Wang M, Wu H, Duan M, Yang Y, Wang G, Che F, Liu B, He W, Li Q, Zhang L. SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells. Life Sci 2019;232:116663. [PMID: 31323275 DOI: 10.1016/j.lfs.2019.116663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Bamburowicz-Klimkowska M, Poplawska M, Grudzinski IP. Nanocomposites as biomolecules delivery agents in nanomedicine. J Nanobiotechnology 2019;17:48. [PMID: 30943985 DOI: 10.1186/s12951-019-0479-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
16 Wu M, Chen J, Veroniaina H, Mukhopadhyay S, Wu Z, Wu Z, Qi X. Pea-like nanocabins enable autonomous cruise and step-by-step drug pushing for deep tumor inhibition. Nanomedicine 2019;18:122-34. [PMID: 30858086 DOI: 10.1016/j.nano.2019.02.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Bahreyni A, Alibolandi M, Ramezani M, Sarafan Sadeghi A, Abnous K, Taghdisi SM. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo. Colloids Surf B Biointerfaces 2019;175:231-8. [PMID: 30537619 DOI: 10.1016/j.colsurfb.2018.12.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
18 Yang S, Li H, Xu L, Deng Z, Han W, Liu Y, Jiang W, Zu Y. Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies. Mol Ther Nucleic Acids 2018;13:164-75. [PMID: 30292138 DOI: 10.1016/j.omtn.2018.08.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]